Wait for it... we really do not yet know the long-term costs and consequences (health outcomes) of a regime of weight-loss drugs over self discipline. Let's see, we have had thalidomide, LSD, oxycontin, fentanyl... to name just a few drugs that were claimed to have great promise and brought great pain and suffering (and personal and social costs).
You're concerned that people might construe Ozempic as being 'bad for business [across the board]'?
Ie not just that it will create winners and losers, but that it will lead to less 'business' overall. Which in macro terms we might characterise as a drop in aggregate demand?
Fantastic piece!
Thank you 🙏
Wait for it... we really do not yet know the long-term costs and consequences (health outcomes) of a regime of weight-loss drugs over self discipline. Let's see, we have had thalidomide, LSD, oxycontin, fentanyl... to name just a few drugs that were claimed to have great promise and brought great pain and suffering (and personal and social costs).
Considering your comment is so off-topic, I figured an off topic response was reasonable.
Could you point out the harm that LSD has wrought? That seems the most egregious example.
But all of the other drugs (except thalidomide) are also valuable in a clinical setting, and are still beneficial when used as intended.
You're concerned that people might construe Ozempic as being 'bad for business [across the board]'?
Ie not just that it will create winners and losers, but that it will lead to less 'business' overall. Which in macro terms we might characterise as a drop in aggregate demand?